MEI Pharma's total assets for Q3 2025 were $20.78M, a decrease of -14.79% from the previous quarter. MEIP total liabilities were $1.24M for the fiscal quarter, a -45.87% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.